1. Home
  2. LIVN

as of 12-09-2025 3:53pm EST

$61.97
$0.04
-0.06%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Chart Type:
Time Range:
Founded: 1987 Country:
United Kingdom
United Kingdom
Employees: N/A City: LONDON
Market Cap: 3.5B IPO Year: 1993
Target Price: $62.43 AVG Volume (30 days): 637.8K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.99 EPS Growth: N/A
52 Week Low/High: $32.48 - $64.45 Next Earning Date: 11-05-2025
Revenue: $1,348,962,000 Revenue Growth: 8.63%
Revenue Growth (this year): 12.25% Revenue Growth (next year): 6.75%

AI-Powered LIVN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 15 hours ago

AI Recommendation

hold
Model Accuracy: 74.32%
74.32%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of LivaNova PLC (LIVN)

Sell
LIVN Nov 18, 2025

Avg Cost/Share

$53.94

Shares

250

Total Value

$13,485.00

Owned After

6,232

SEC Form 4

Share on Social Networks: